BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Design of magnetic nanoparticles for diagnostics and cell activati
 ons
DTSTART:20130723T110000
DTSTAMP:20260917T150126Z
UID:cff89af222909c4df737fa04d9efa43cfc891312afb2917b54f2adcf
CATEGORIES:Conferences - Seminars
DESCRIPTION:Prof. Jinwoo Cheon\nBio: Jinwoo Cheon graduated from Yonsei Un
 iversity with B.S. and earned his Ph.D. from University of Illinois\, Urba
 na-Champaign in 1993. After post-doctoral training studying inorganic mate
 rials chemistry at U.C. Berkeley and UCLA\, he joined the faculty of Korea
  Advanced Institute of Science and Technology (KAIST). In 2002\, he moved 
 to Yonsei University.\nJinwoo Cheon is a senior editor of Accounts of Chem
 ical Research (American Chemical Society)\, and an editorial board member 
 of Nano Letters (American Chemical Society). He is a fellow of Royal Socie
 ty of Chemistry and a member of the Korean Academy of Science and Technolo
 gy.\nHe has been merited with numerous awards including Inchon Prize (2010
 )\, Knowledge Creation Award (2010)\, Korean Top 10 Next Leaders in Scienc
 e (Sisa Press\, 2008)\, Song-gok Science Award (2007)\, Yonsei Research Ac
 hievement Award (2006)\, the Korean Chemical Society Award in Inorganic Ch
 emistry (2004)\, the National Science Prize for Junior Faculty (2002: pres
 ented by the President of Korea)\, and the Wiley Young Chemist Award (2001
 ).\nOne of the important trends of next-generation nanomedicine is therano
 stics that is defined by the combination of therapeutics and diagnostics o
 n a single platform. Magnetic nanoparticles are among one of the most esse
 ntial platforms for targeted imaging\, therapy\, and simultaneous monitori
 ng of therapeutic efficacy. In this talk\, I will discuss magnetic nanopar
 ticles as a core platform material for theranostics and add a variety of f
 unctionalities such as drug\, targeting moiety\, and gene to enhance their
  performance. Their unique utilization in highly accurate dual-modal MR im
 aging\, therapeutic hyperthermia of cancer cells\, controlled drug release
 \, gene delivery\, and molecular level cell signaling and cell fate contro
 l will be discussed.
LOCATION:MXF 1 https://plan.epfl.ch/?room==MXF%201
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR